103 related articles for article (PubMed ID: 12509980)
1. Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein.
Beucher M; Meira WS; Zegarra V; Galvão LM; Chiari E; Norris KA
Protein Expr Purif; 2003 Jan; 27(1):19-26. PubMed ID: 12509980
[TBL] [Abstract][Full Text] [Related]
2. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.
Norris KA
Infect Immun; 1998 Jun; 66(6):2460-5. PubMed ID: 9596703
[TBL] [Abstract][Full Text] [Related]
3. Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.
Norris KA; Schrimpf JE; Szabo MJ
Infect Immun; 1997 Feb; 65(2):349-57. PubMed ID: 9009282
[TBL] [Abstract][Full Text] [Related]
4. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.
Tambourgi DV; Kipnis TL; da Silva WD; Joiner KA; Sher A; Heath S; Hall BF; Ogden GB
Infect Immun; 1993 Sep; 61(9):3656-63. PubMed ID: 7689538
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
Norris KA; Bradt B; Cooper NR; So M
J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
[TBL] [Abstract][Full Text] [Related]
6. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family.
Beucher M; Norris KA
Infect Immun; 2008 Feb; 76(2):750-8. PubMed ID: 18070905
[TBL] [Abstract][Full Text] [Related]
7. Exploring the FL-160-CRP gene family through sequence variability of the complement regulatory protein (CRP) expressed by the trypomastigote stage of Trypanosoma cruzi.
Mathieu-Daudé F; Lafay B; Touzet O; Lelièvre J; Parrado F; Bosseno MF; Rojas AM; Fatha S; Ouaissi A; Brenière SF
Infect Genet Evol; 2008 May; 8(3):258-66. PubMed ID: 18296127
[TBL] [Abstract][Full Text] [Related]
8. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi.
Norris KA; Schrimpf JE
Infect Immun; 1994 Jan; 62(1):236-43. PubMed ID: 8262633
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
10. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
Norris KA
Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
[TBL] [Abstract][Full Text] [Related]
11. Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.
Arroyo-Olarte RD; Martínez I; Cruz-Rivera M; Mendlovic F; Espinoza B
Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170332. PubMed ID: 29513875
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the virulence of T. cruzi strains, complement regulatory protein expression levels, and the ability to elicit lytic antibody production.
Henrique PM; Marques T; da Silva MV; Nascentes GAN; de Oliveira CF; Rodrigues V; Gómez-Hernández C; Norris KA; Ramirez LE; Meira WSF
Exp Parasitol; 2016 Nov; 170():66-72. PubMed ID: 27614283
[TBL] [Abstract][Full Text] [Related]
13. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
14. Homologous Expression of Glycosylphosphatidylinositol-Anchored Glycoproteins in Trypanosoma cruzi.
Balouz V; Mesias AC; Camean CC; Ducrey I; Lobo MM; Durante IM; Cánepa GE; Buscaglia CA; de Los Milagros Cámara M
Methods Mol Biol; 2019; 1955():119-134. PubMed ID: 30868523
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.
Halabian R; Fathabad ME; Masroori N; Roushandeh AM; Saki S; Amirizadeh N; Najafabadi AJ; Gharehbaghian A; Roudkenar MH
Blood Transfus; 2009 Oct; 7(4):305-12. PubMed ID: 20011642
[TBL] [Abstract][Full Text] [Related]
16. Identification of complement regulatory domains in human factor H.
Gordon DL; Kaufman RM; Blackmore TK; Kwong J; Lublin DM
J Immunol; 1995 Jul; 155(1):348-56. PubMed ID: 7541419
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional analysis of mouse decay accelerating factor (CD55).
Harris CL; Rushmere NK; Morgan BP
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
[TBL] [Abstract][Full Text] [Related]
18. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite.
Campos MA; Almeida IC; Takeuchi O; Akira S; Valente EP; Procópio DO; Travassos LR; Smith JA; Golenbock DT; Gazzinelli RT
J Immunol; 2001 Jul; 167(1):416-23. PubMed ID: 11418678
[TBL] [Abstract][Full Text] [Related]
19. Engineering of recombinant soluble CD46: an inhibitor of complement activation.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Mottram PL; Purcell LJ; Loveland BE
Immunology; 1996 Mar; 87(3):348-54. PubMed ID: 8778018
[TBL] [Abstract][Full Text] [Related]
20. Distinct genomic organization, mRNA expression and cellular localization of members of two amastin sub-families present in Trypanosoma cruzi.
Kangussu-Marcolino MM; de Paiva RM; Araújo PR; de Mendonça-Neto RP; Lemos L; Bartholomeu DC; Mortara RA; daRocha WD; Teixeira SM
BMC Microbiol; 2013 Jan; 13():10. PubMed ID: 23327097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
